PL1761779T3 - Zastosowanie transtyretyny jako biomarkera gruczolaka jelita grubego; sposób wykrywania i układ testowy - Google Patents
Zastosowanie transtyretyny jako biomarkera gruczolaka jelita grubego; sposób wykrywania i układ testowyInfo
- Publication number
- PL1761779T3 PL1761779T3 PL04764118T PL04764118T PL1761779T3 PL 1761779 T3 PL1761779 T3 PL 1761779T3 PL 04764118 T PL04764118 T PL 04764118T PL 04764118 T PL04764118 T PL 04764118T PL 1761779 T3 PL1761779 T3 PL 1761779T3
- Authority
- PL
- Poland
- Prior art keywords
- colorectal
- transthyretin
- colorectal adenoma
- biomarker
- detection
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04764118A EP1761779B1 (en) | 2004-08-13 | 2004-08-13 | Use of transthyretin as a biomarker for colorectal adenoma ; method for detection and test system |
| PCT/EP2004/009124 WO2006015616A1 (en) | 2004-08-13 | 2004-08-13 | Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1761779T3 true PL1761779T3 (pl) | 2008-04-30 |
Family
ID=34958684
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04764118T PL1761779T3 (pl) | 2004-08-13 | 2004-08-13 | Zastosowanie transtyretyny jako biomarkera gruczolaka jelita grubego; sposób wykrywania i układ testowy |
| PL05772471T PL1776587T3 (pl) | 2004-08-13 | 2005-08-11 | Zastosowanie C3A i jego pochodnych jako biomarkera do leczenia gruczolaka i/lub raka jelita grubego; metody diagnostyczne i testy z ich użyciem |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05772471T PL1776587T3 (pl) | 2004-08-13 | 2005-08-11 | Zastosowanie C3A i jego pochodnych jako biomarkera do leczenia gruczolaka i/lub raka jelita grubego; metody diagnostyczne i testy z ich użyciem |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7951528B2 (pl) |
| EP (3) | EP1843159A1 (pl) |
| JP (2) | JP4916441B2 (pl) |
| KR (1) | KR20070051328A (pl) |
| CN (2) | CN101014859A (pl) |
| AT (2) | ATE376674T1 (pl) |
| AU (2) | AU2004322162B2 (pl) |
| BR (1) | BRPI0419002A (pl) |
| CA (2) | CA2577601A1 (pl) |
| DE (2) | DE602004009716T2 (pl) |
| DK (2) | DK1761779T3 (pl) |
| ES (2) | ES2295907T3 (pl) |
| IL (2) | IL181132A (pl) |
| MX (2) | MX2007001479A (pl) |
| NO (2) | NO20070598L (pl) |
| PL (2) | PL1761779T3 (pl) |
| PT (2) | PT1761779E (pl) |
| SI (1) | SI1776587T1 (pl) |
| WO (2) | WO2006015616A1 (pl) |
| ZA (1) | ZA200701188B (pl) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2577601A1 (en) | 2004-08-13 | 2006-02-16 | Indivumed Gmbh | Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system |
| EP1775590A1 (en) * | 2005-10-11 | 2007-04-18 | Laboratorios S.A.L.V.A.T., S.A. | Non-invasive in vitro method to detect transitional cell carcinoma of the bladder |
| JP4748671B2 (ja) * | 2006-03-16 | 2011-08-17 | 日東紡績株式会社 | 食道扁平上皮癌マーカーおよびそれを利用した食道扁平上皮癌の判定方法 |
| KR100819122B1 (ko) | 2006-09-30 | 2008-04-04 | 남명진 | 췌장암 진단용 키트 |
| WO2009025080A1 (ja) * | 2007-08-18 | 2009-02-26 | School Juridical Person Kitasato Institute | 大腸癌マーカポリペプチド、及び大腸癌の診断方法 |
| JP5203687B2 (ja) * | 2007-12-12 | 2013-06-05 | シスメックス株式会社 | 動物検査情報提供システム、中央装置、動物検査情報提供方法及びコンピュータプログラム |
| CN101838683B (zh) * | 2008-12-12 | 2013-09-18 | 深圳华大基因科技有限公司 | 一种kras基因和/或braf基因的核苷酸突变位点的检测方法 |
| CN102147396B (zh) * | 2010-02-10 | 2014-01-01 | 桑建利 | 人血液样本中脂类分子含量测定及其结直肠腺瘤诊断试剂盒制备与应用 |
| JP2013253780A (ja) * | 2010-10-12 | 2013-12-19 | Katakura Industries Co Ltd | うつ病の診断のためのデータの提供方法 |
| US10158898B2 (en) | 2012-07-26 | 2018-12-18 | Comcast Cable Communications, Llc | Customized options for consumption of content |
| BR112015012616A2 (pt) * | 2012-11-30 | 2017-09-12 | Applied Proteomics Inc | método para avaliação da presença ou risco de tumores de cólon |
| CN104056277B (zh) * | 2013-03-21 | 2019-07-05 | 中国人民解放军第二军医大学 | Mlh1基因或其表达产物在dkk4高表达的结直肠癌中的应用 |
| US20170176441A1 (en) * | 2014-03-28 | 2017-06-22 | Applied Proteomics, Inc. | Protein biomarker profiles for detecting colorectal tumors |
| CN107110865B (zh) * | 2014-08-22 | 2020-01-10 | 雅培制药有限公司 | 用于结肠直肠癌的早期检测的方法 |
| CN105988006A (zh) * | 2015-02-10 | 2016-10-05 | 张曼 | 尿液补体c3蛋白的应用 |
| JP2018517892A (ja) | 2015-04-10 | 2018-07-05 | アプライド プロテオミクス，インク． | 結腸直腸癌と進行腺腫を検知するためのタンパク質バイオマーカーパネル |
| US20180092874A1 (en) * | 2016-10-03 | 2018-04-05 | Lincoln Memorial University | Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment |
| KR102018205B1 (ko) * | 2017-07-24 | 2019-09-05 | (주) 바이오인프라생명과학 | 대장암 진단용 조성물 및 상기 조성물을 이용한 대장암 진단 방법 |
| GB201721569D0 (en) * | 2017-12-21 | 2018-02-07 | Belgian Volition Sprl | Method for the detection and treatment of colorectal adenomas |
| GB201808476D0 (en) * | 2018-05-23 | 2018-07-11 | Univ Liverpool | Biomarkers for colorectal cancer |
| WO2023282916A1 (en) | 2021-07-09 | 2023-01-12 | Guardant Health, Inc. | Methods of detecting genomic rearrangements using cell free nucleic acids |
| CN116449018B (zh) * | 2023-02-14 | 2023-09-05 | 浙江大学 | 一种用于肠腺瘤腺癌诊断的血浆蛋白标记物及应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4996298A (en) * | 1988-04-20 | 1991-02-26 | New England Deaconess Hospital Corporation | Marker for colorectal carcinoma and methods of detecting the same |
| US5654161A (en) | 1995-05-12 | 1997-08-05 | Chiron Diagnostics Corporation | Method for diagnosing prostate cancer |
| DE19711111C2 (de) | 1997-03-06 | 1999-09-02 | Schering Ag | In vitro Nachweis zur Erkennung von Darmtumoren |
| US6221621B1 (en) | 1997-03-06 | 2001-04-24 | Bard Diagnostic Sciences, Inc. | Methods of screening for colorectal cancers in which a complement Factor I or related protein is associated |
| IL121134A0 (en) * | 1997-06-22 | 1997-11-20 | Yeda Res & Dev | Peptides and antiallergic compositions comprising them |
| US20020160394A1 (en) | 2001-01-24 | 2002-10-31 | Bayer Corporation | Regulation of transthyretin to treat obesity |
| WO2003000182A2 (en) | 2001-06-22 | 2003-01-03 | Merck & Co., Inc. | Ppar-alpha ligands for the treatment or prevention of cachexia |
| US7144708B2 (en) * | 2001-06-25 | 2006-12-05 | The Cleveland Clinic Foundation | Markers of blood barrier disruption and methods of using same |
| DE10224534A1 (de) | 2002-05-31 | 2003-12-11 | Juergen Dolderer | Verfahren zum Diagnostizieren des colorektaien Karzinoms in einer Gewebeprobe und Mittel zur Behandlung |
| US20060199179A1 (en) | 2002-06-19 | 2006-09-07 | Oncotherapy Science, Inc. | Method for diagnosis of colorectal tumors |
| EP1540010B8 (en) | 2002-08-06 | 2010-07-14 | The Johns Hopkins University | Use of biomarkers for detecting ovarian cancer |
| EP1613966A2 (en) * | 2003-04-08 | 2006-01-11 | Colotech A/S | A method for detection of colorectal cancer in human samples |
| US7268117B2 (en) * | 2003-07-11 | 2007-09-11 | Praecis Pharmaceuticals Incorporated | Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis |
| DK1776464T3 (da) | 2004-08-13 | 2010-02-01 | Egomedical Technologies Ag | analyt.-testsytem til bestemmelse af koncentrationen af en analyt i en fysiologisk eller vandig væske |
| CA2577601A1 (en) * | 2004-08-13 | 2006-02-16 | Indivumed Gmbh | Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system |
| US9075062B2 (en) | 2005-03-22 | 2015-07-07 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Identification of biomarkers by serum protein profiling |
-
2004
- 2004-08-13 CA CA002577601A patent/CA2577601A1/en not_active Abandoned
- 2004-08-13 PT PT04764118T patent/PT1761779E/pt unknown
- 2004-08-13 EP EP07014481A patent/EP1843159A1/en not_active Withdrawn
- 2004-08-13 EP EP04764118A patent/EP1761779B1/en not_active Not-in-force
- 2004-08-13 MX MX2007001479A patent/MX2007001479A/es unknown
- 2004-08-13 JP JP2007525176A patent/JP4916441B2/ja not_active Expired - Fee Related
- 2004-08-13 DE DE602004009716T patent/DE602004009716T2/de active Active
- 2004-08-13 DK DK04764118T patent/DK1761779T3/da active
- 2004-08-13 AT AT04764118T patent/ATE376674T1/de active
- 2004-08-13 AU AU2004322162A patent/AU2004322162B2/en not_active Ceased
- 2004-08-13 ES ES04764118T patent/ES2295907T3/es active Active
- 2004-08-13 US US11/660,070 patent/US7951528B2/en not_active Expired - Fee Related
- 2004-08-13 WO PCT/EP2004/009124 patent/WO2006015616A1/en active IP Right Grant
- 2004-08-13 PL PL04764118T patent/PL1761779T3/pl unknown
- 2004-08-13 BR BRPI0419002-5A patent/BRPI0419002A/pt not_active IP Right Cessation
- 2004-08-13 CN CNA2004800437997A patent/CN101014859A/zh active Pending
-
2005
- 2005-08-11 PT PT05772471T patent/PT1776587E/pt unknown
- 2005-08-11 PL PL05772471T patent/PL1776587T3/pl unknown
- 2005-08-11 MX MX2007001254A patent/MX2007001254A/es active IP Right Grant
- 2005-08-11 KR KR1020077005868A patent/KR20070051328A/ko not_active Application Discontinuation
- 2005-08-11 DE DE602005012108T patent/DE602005012108D1/de active Active
- 2005-08-11 WO PCT/EP2005/008742 patent/WO2006053592A1/en active Application Filing
- 2005-08-11 CN CNA2005800276025A patent/CN101014861A/zh active Pending
- 2005-08-11 ES ES05772471T patent/ES2322378T3/es active Active
- 2005-08-11 US US11/660,066 patent/US7883842B2/en not_active Expired - Fee Related
- 2005-08-11 DK DK05772471T patent/DK1776587T3/da active
- 2005-08-11 JP JP2007525256A patent/JP4592753B2/ja not_active Expired - Fee Related
- 2005-08-11 SI SI200530641T patent/SI1776587T1/sl unknown
- 2005-08-11 CA CA002576998A patent/CA2576998A1/en not_active Abandoned
- 2005-08-11 AT AT05772471T patent/ATE419534T1/de active
- 2005-08-11 AU AU2005306103A patent/AU2005306103A1/en not_active Abandoned
- 2005-08-11 ZA ZA200701188A patent/ZA200701188B/xx unknown
- 2005-08-11 EP EP05772471A patent/EP1776587B9/en not_active Not-in-force
-
2007
- 2007-01-31 NO NO20070598A patent/NO20070598L/no not_active Application Discontinuation
- 2007-01-31 NO NO20070599A patent/NO20070599L/no not_active Application Discontinuation
- 2007-02-01 IL IL181132A patent/IL181132A/en not_active IP Right Cessation
- 2007-02-01 IL IL181131A patent/IL181131A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL181132A0 (en) | Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system | |
| GB2427468B (en) | Cell separation device and method for the detection of EpCAM positive cells | |
| WO2008095152A3 (en) | Methods and materials for identifying the origin of a carcinoma of unknown primary origin | |
| WO2005041893A3 (en) | Detection of acute myocardial infarction biomarkers | |
| WO2007035676A3 (en) | Methods and materials for identifying the origin of a carcinoma of unknown primary origin | |
| WO2013093635A3 (en) | Plasma micrornas for the detection of early colorectal cancer | |
| WO2006023769A3 (en) | Determining data quality and/or segmental aneusomy using a computer system | |
| EP1415152A4 (en) | METHOD, DEVICES AND COMPUTER PROGRAMS FOR VERIFYING THE INTEGRITY OF A PROBE | |
| WO2010033371A3 (en) | Molecular markers for lung and colorectal carcinomas | |
| WO2007005666A3 (en) | System and method of analyte detection using differential receptors | |
| EP3156925A3 (en) | Copd biomarker signatures | |
| ECSP056124A (es) | Método y dispositivo para detectar analitos volátiles en muestras de aire | |
| MX2021008520A (es) | Metodos y sistemas para deteccion de analitos. | |
| WO2010009074A3 (en) | Method for predicting and detecting tumor metastasis | |
| WO2004057336A3 (en) | Use of nicotinamide n-methyltransferase as a marker for colorectal cancer | |
| WO2004058051A3 (en) | Androgen-regulated genes and uses for diagnosis, prognosis and treatment of prostate neoplastic conditions | |
| IL189185A0 (en) | Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system | |
| NO20053276L (no) | Fremgangsmate og hjelpemiddel for pavisning av mykoplasma. | |
| WO2004090780A3 (en) | Determining the quality of biomolecule samples | |
| WO2007062142A3 (en) | Method for identifying biomarkers associated with cancer | |
| WO2006019991A3 (en) | Method and apparatus for multimodal detection | |
| DK1416278T3 (da) | Fremgangsmåder til forbedret diagnosticering af dysplasier | |
| EP1852513A3 (en) | Method for diagnosing cancer using cancer-associated deletion gene marker | |
| MX2017008959A (es) | Biomarcadores relacionados con la funcion del riñon y metodos que involucran su uso. |